References
- Ashley R L, Corey L. Effect of acyclovir treatment of primary genital herpes on the antibody response to herpes simplex virus. J Clin Invest 1984; 73: 681
- Ashley R L, Benedetti J, Corey L. Humoral immune response to HSV-2 viral proteins in patients with primary genital herpes. J Med Virol 1985; 17: 153
- Bernstein D I, Lovet M A, Bryson Y LC. The effects of acyclovir on antibody response to herpes simplex virus in primary genital herpetic infections. J Infect Dis 1984; 150: 7
- Crumpacher C S, Schnipper L E, Zaia J A, Levin M I. Growth inhibition of acycloguanosine of herpes virus isolated from human infections. Antimicrob Agents Chemother 1979; 15: 642
- Douglas R G, Couch R B. A prospective study of chronic herpes simplex virus infection and recurrent herpes labialis in humans. J Immunol 1970; 104: 289
- Eberle R S, Mou W, Zaia J A. Polypeptide specificity of the early antibody response following primary and recurrent genital herpes simplex virus type-2 infections. J Gen Virol 1984; 65: 1839
- Eisenberg R, Ponce de Leon M, Pereira I, Long D H, Cohen G H. Purification of glycoprotein gD of herpes simplex virus types 1 and 2 by use of monoclonal antibody. J Virol 1982; 41: 1099
- Iwasaka T, Sheridan J F, Aurelion L. Immunity to herpes simplex virus type 2. Infect Immun 1983; 42(3)955
- Kahlon J, Lakeman F D, Ackermann M, Whitley R. Human antibody response to herpes simplex virus-specific polypeptides after primary and recurrent infection. J Clin Microbiol 1986; 23(4)725
- Klein R J, Friedman A E, Yellia P B. Orofacial herpes simplex virus infection in hairless mice. Latent virus in trigeminal ganglia after topical antiviral treatment. Infect Immun 1978; 20: 130
- Kohl S, Adam E, Matson D, Kaufman R H, Dreesman G R. Kinetics of human antibody response to primary genital herpes simplex virus infection. Int Virol 1982; 18: 164
- Lagace-Simard J, Portnoy J D, Wainberg M A. High levels of IgE in patients suffering from frequent recurrent herpes simplex lesions. J Allergy Clin Immunol 1986; 77(4)582
- Lehner T, Wilton J MA, Shillitae E J. Immunological basis for latency recurrences and putative oncogenic-ity of herpes simplex virus. Lancet 1975; ii: 60
- Merriman H, Woods S, Winter C, Fahnlander A, Corey L. Secretory IgA antibody in cervicovaginal secretions from women with genital infection due to HSV. J Infect Dis 1984; 149(4)505
- Nash A A, Wildy P. Immunity in relation to the pathogenesis of HSV. Human Immunity to Viruses, F A Ennis. Academic Press, New York 1983; 179
- Oakes J E, Rosemond-Hornbeak H. Antibody mediated recovery from subcutaneous herpes simplex virus type 2 infection. Infect Immun 1978; 21: 489
- Pien F D, Smith T F, Anderson C F, Webel M L, Taswell H F. Herpes-viruses in renal transplant patients. Transplantation 1973; 16: 489
- Raab B, Lorincz A L. Genital herpes simplex. J Am Acad Dermatol 1981; 5: 249
- Reeves W C, Corey L, Adams H G, Vontver L A, Holmes K K. Risk of recurrence after first episodes of genital herpes. Relation to HSV type and antibody response. N Engl J Med 1981; 305: 315
- Rouse B T, Babiuk L A. Mechanisms of recovery from herpes virus infections—a review. Can J Comp Med 1978; 42: 414
- Sekizawa T, et al. Latency of herpes simplex virus in absence of neutralizing antibody: model for reactivation. Science 1980; 210: 1026
- Sim C, Watson D H. The role of type specific and cross reacting structural antigens in the neutralization of herpes simplex virus types 1 and 2. J Gen Virol 1973; 19: 217
- Simmons A, Nash A. Role of antibody in primary and recurrent herpes simplex virus infection. J Virol 1985; 53(3)944
- Stevens J G, Cook M L. Maintenance of latent herpetic infection: an apparent role for anti-viral IgG. J Immunol 1974; 113: 1685
- Waltz M A, Yamamoto H, Notkins A L. Immunological response restricts number of cells in sensory ganglia infected with herpes simplex virus. Nature 1976; 264: 554
- Weller T H, Coons A H. Fluorescent antibody studies with agents of varicella and herpes zoster propagated in vitro. Proc Soc Exp Biol Med 1954; 86: 789
- Zweerink H, Corey L. Virus specific antibodies in sera from patients with genital herpes simplex virus infection. Infect Immun 1982; 37: 413